Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
With only a change of €0.15 (0.090%) the Quest Diagnostics Inc. price is nearly unchanged from yesterday.
Our community is currently high on Quest Diagnostics Inc. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 170 € shows a slightly positive potential of 3.66% compared to the current price of 164.0 € for Quest Diagnostics Inc..
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | 0.090% | -3.953% | -5.990% | 13.495% | 9.956% | 24.431% | 52.700% |
| Anthem Inc. | 0.480% | 3.029% | 5.208% | -30.694% | -8.730% | -40.289% | -10.493% |
| HCA Holdings Inc. | 0.430% | 3.398% | -9.325% | 43.975% | 5.015% | 70.840% | 169.341% |
| Universal Health Services B | -0.650% | 1.299% | -3.106% | 0.645% | -18.750% | 25.806% | 35.770% |
Comments
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat